The comparison of ramosetron with ramosetron plus dexamethasone for postoperative nausea and vomitting after laparoscopic cholecystectomy.

Trial Profile

The comparison of ramosetron with ramosetron plus dexamethasone for postoperative nausea and vomitting after laparoscopic cholecystectomy.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Ramosetron (Primary) ; Dexamethasone
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 15 Feb 2012 Planned number of patients changed from 150 to 76 as reported by Clinical Research Information Service (CriS) - Republic of Korea record.
    • 20 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top